1.
Comparison of the use of 5-fluorouracil and bevacizumab in primary trabeculectomy: results at 1 year.
Jurkowska-Dudzińska Justyna, Kosior-Jarecka Ewa, Zarnowski Tomasz
Clin Exp OphthalmolJun 201227 citationsClinical Trial
This study compared 5-FU and bevacizumab as trabeculectomy adjuvants. Both achieved similar 1-year IOP reduction, but bevacizumab patients required more additional medication for control.